DMH4 |
A VEGFR2 inhibitor (IC50 = 0.16 µM in a cell-free assay); selectivel… |
10 mg |
27653-10 |
More Info
|
DMH4 |
A VEGFR2 inhibitor (IC50 = 0.16 µM in a cell-free assay); selectivel… |
25 mg |
27653-25 |
More Info
|
DMH4 |
A VEGFR2 inhibitor (IC50 = 0.16 µM in a cell-free assay); selectivel… |
5 mg |
27653-5 |
More Info
|
DMHAPC-Chol |
A cationic cholesterol; a component of liposomes used for DNA plasmid deli… |
1 mg |
26582-1 |
More Info
|
DMHAPC-Chol |
A cationic cholesterol; a component of liposomes used for DNA plasmid deli… |
10 mg |
26582-10 |
More Info
|
DMHAPC-Chol |
A cationic cholesterol; a component of liposomes used for DNA plasmid deli… |
25 mg |
26582-25 |
More Info
|
DMHAPC-Chol |
A cationic cholesterol; a component of liposomes used for DNA plasmid deli… |
5 mg |
26582-5 |
More Info
|
DMHCA |
An LXR agonist; activates LXRα and LXRβ in CV-1 cells expressin… |
1 mg |
37712-1 |
More Info
|
DMHCA |
An LXR agonist; activates LXRα and LXRβ in CV-1 cells expressin… |
10 mg |
37712-10 |
More Info
|
DMHCA |
An LXR agonist; activates LXRα and LXRβ in CV-1 cells expressin… |
25 mg |
37712-25 |
More Info
|
DMHCA |
An LXR agonist; activates LXRα and LXRβ in CV-1 cells expressin… |
5 mg |
37712-5 |
More Info
|
DM4 (hydrate) |
A derivative of maytansine; cytotoxic to SK-BR-3 cells (IC50 = 3.3 nM); se… |
10 mg |
34121-10 |
More Info
|
DM4 (hydrate) |
A derivative of maytansine; cytotoxic to SK-BR-3 cells (IC50 = 3.3 nM); se… |
25 mg |
34121-25 |
More Info
|
DM4 (hydrate) |
A derivative of maytansine; cytotoxic to SK-BR-3 cells (IC50 = 3.3 nM); se… |
5 mg |
34121-5 |
More Info
|
DM4 (hydrate) |
A derivative of maytansine; cytotoxic to SK-BR-3 cells (IC50 = 3.3 nM); se… |
50 mg |
34121-50 |
More Info
|
D-(−)-3-Phosphoglyceric Acid (sodium salt) |
An intermediate in glycolysis / gluconeogenesis and the biosynthesis of se… |
1 g |
20123-1 |
More Info
|
D-(−)-3-Phosphoglyceric Acid (sodium salt) |
An intermediate in glycolysis / gluconeogenesis and the biosynthesis of se… |
10 mg |
20123-10 |
More Info
|
D-(−)-3-Phosphoglyceric Acid (sodium salt) |
An intermediate in glycolysis / gluconeogenesis and the biosynthesis of se… |
100 mg |
20123-100 |
More Info
|
D-(−)-3-Phosphoglyceric Acid (sodium salt) |
An intermediate in glycolysis / gluconeogenesis and the biosynthesis of se… |
50 mg |
20123-50 |
More Info
|
D-(−)-Quinic Acid |
A hydroxylated cyclohexane carboxylic acid with diverse biological activit… |
10 g |
30212-10 |
More Info
|
D-(−)-Quinic Acid |
A hydroxylated cyclohexane carboxylic acid with diverse biological activit… |
100 g |
30212-100 |
More Info
|
D-(−)-Quinic Acid |
A hydroxylated cyclohexane carboxylic acid with diverse biological activit… |
25 g |
30212-25 |
More Info
|
D-(−)-Quinic Acid |
A hydroxylated cyclohexane carboxylic acid with diverse biological activit… |
50 g |
30212-50 |
More Info
|
D-(−)-Tagatose |
A natural non-caloric sweetener and hexose monosaccharide; metabolized by… |
1 g |
39233-1 |
More Info
|
D-(−)-Tagatose |
A natural non-caloric sweetener and hexose monosaccharide; metabolized by… |
10 g |
39233-10 |
More Info
|
D-(−)-Tagatose |
A natural non-caloric sweetener and hexose monosaccharide; metabolized by… |
25 g |
39233-25 |
More Info
|
D-(−)-Tagatose |
A natural non-caloric sweetener and hexose monosaccharide; metabolized by… |
5 g |
39233-5 |
More Info
|
2,5-DMMA |
A designer drug that combines the 2,5 disubstitution pattern of 2,5-dimeth… |
10 mg |
15131-10 |
More Info
|
2,5-DMMA |
A designer drug that combines the 2,5 disubstitution pattern of 2,5-dimeth… |
5 mg |
15131-5 |
More Info
|
2,5-DMMA |
A designer drug that combines the 2,5 disubstitution pattern of 2,5-dimeth… |
50 mg |
15131-50 |
More Info
|
3,4-DMMA (hydrochloride) |
An MDMA analog that appears to act as a serotonin-norepinephrine-dopamine… |
10 mg |
11128-10 |
More Info
|
3,4-DMMA (hydrochloride) |
An MDMA analog that appears to act as a serotonin-norepinephrine-dopamine… |
5 mg |
11128-5 |
More Info
|
3,4-DMMA (hydrochloride) |
An MDMA analog that appears to act as a serotonin-norepinephrine-dopamine… |
50 mg |
11128-50 |
More Info
|
DMNQ |
A 1,4-naphthoquinone that acts as a redox-cycling agent, typically increas… |
10 mg |
19571-10 |
More Info
|
DMNQ |
A 1,4-naphthoquinone that acts as a redox-cycling agent, typically increas… |
25 mg |
19571-25 |
More Info
|
DMNQ |
A 1,4-naphthoquinone that acts as a redox-cycling agent, typically increas… |
5 mg |
19571-5 |
More Info
|
DMOG |
A cell permeable, competitive inhibitor of HIF-1α prolyl hydroxylase… |
10 mg |
71210-10 |
More Info
|
DMOG |
A cell permeable, competitive inhibitor of HIF-1α prolyl hydroxylase… |
100 mg |
71210-100 |
More Info
|
DMOG |
A cell permeable, competitive inhibitor of HIF-1α prolyl hydroxylase… |
50 mg |
71210-50 |
More Info
|
DMOG |
A cell permeable, competitive inhibitor of HIF-1α prolyl hydroxylase… |
500 mg |
71210-500 |
More Info
|
DMP 543 |
An inhibitor of Kv7.2 (IC50 = 0.048 µM); enhances potassium-induced… |
1 mg |
32849-1 |
More Info
|
DMP 543 |
An inhibitor of Kv7.2 (IC50 = 0.048 µM); enhances potassium-induced… |
10 mg |
32849-10 |
More Info
|
DMP 543 |
An inhibitor of Kv7.2 (IC50 = 0.048 µM); enhances potassium-induced… |
5 mg |
32849-5 |
More Info
|
DMPAC-Chol |
A cationic cholesterol derivative; has been used in liposome formation for… |
1 mg |
26583-1 |
More Info
|
DMPAC-Chol |
A cationic cholesterol derivative; has been used in liposome formation for… |
10 mg |
26583-10 |
More Info
|
DMPAC-Chol |
A cationic cholesterol derivative; has been used in liposome formation for… |
5 mg |
26583-5 |
More Info
|
DMPE-MPEG(2000) |
A PEGylated form of DMPE; has been used in the synthesis of NLCs for use i… |
10 mg |
34649-10 |
More Info
|
DMPE-MPEG(2000) |
A PEGylated form of DMPE; has been used in the synthesis of NLCs for use i… |
100 mg |
34649-100 |
More Info
|
DMPE-MPEG(2000) |
A PEGylated form of DMPE; has been used in the synthesis of NLCs for use i… |
250 mg |
34649-250 |
More Info
|
DMPE-MPEG(2000) |
A PEGylated form of DMPE; has been used in the synthesis of NLCs for use i… |
50 mg |
34649-50 |
More Info
|
DMPO |
A commonly-used spin trap; reacts with O-, N-, S-, and C-centered radicals… |
1 g |
10006436-1 |
More Info
|
DMPO |
A commonly-used spin trap; reacts with O-, N-, S-, and C-centered radicals… |
5 g |
10006436-5 |
More Info
|
DMPO |
A commonly-used spin trap; reacts with O-, N-, S-, and C-centered radicals… |
500 mg |
10006436-500 |
More Info
|
DMPQ (hydrochloride) |
A potent inhibitor of human PDGFRβ (IC50 = 80 nM) |
1 mg |
17551-1 |
More Info
|
DMPQ (hydrochloride) |
A potent inhibitor of human PDGFRβ (IC50 = 80 nM) |
10 mg |
17551-10 |
More Info
|
DMPQ (hydrochloride) |
A potent inhibitor of human PDGFRβ (IC50 = 80 nM) |
5 mg |
17551-5 |
More Info
|
DM1-SMCC |
An antibody-drug conjugate containing the maytansinoid DM1 and the crossli… |
1 mg |
23926-1 |
More Info
|
DM1-SMCC |
An antibody-drug conjugate containing the maytansinoid DM1 and the crossli… |
10 mg |
23926-10 |
More Info
|
DM1-SMCC |
An antibody-drug conjugate containing the maytansinoid DM1 and the crossli… |
25 mg |
23926-25 |
More Info
|
DM1-SMCC |
An antibody-drug conjugate containing the maytansinoid DM1 and the crossli… |
5 mg |
23926-5 |
More Info
|
DM1-SMe |
A mertansine analog; has in vitro activity against the PPTP panel of cance… |
1 mg |
22477-1 |
More Info
|
DM1-SMe |
A mertansine analog; has in vitro activity against the PPTP panel of cance… |
10 mg |
22477-10 |
More Info
|
DM1-SMe |
A mertansine analog; has in vitro activity against the PPTP panel of cance… |
25 mg |
22477-25 |
More Info
|
DM1-SMe |
A mertansine analog; has in vitro activity against the PPTP panel of cance… |
5 mg |
22477-5 |
More Info
|
DMU2105 |
A CYP1B1 inhibitor (IC50 = 0.01 µM); selective for CYP1B1 over CYP1A… |
10 mg |
38522-10 |
More Info
|
DMU2105 |
A CYP1B1 inhibitor (IC50 = 0.01 µM); selective for CYP1B1 over CYP1A… |
25 mg |
38522-25 |
More Info
|
DMU2105 |
A CYP1B1 inhibitor (IC50 = 0.01 µM); selective for CYP1B1 over CYP1A… |
5 mg |
38522-5 |
More Info
|
DMU2105 |
A CYP1B1 inhibitor (IC50 = 0.01 µM); selective for CYP1B1 over CYP1A… |
50 mg |
38522-50 |
More Info
|
DMU2139 |
A CYP1B1 inhibitor (IC50 = 0.009 µM); selective for CYP1B1 over CYP1… |
10 mg |
37301-10 |
More Info
|
DMU2139 |
A CYP1B1 inhibitor (IC50 = 0.009 µM); selective for CYP1B1 over CYP1… |
25 mg |
37301-25 |
More Info
|
DMU2139 |
A CYP1B1 inhibitor (IC50 = 0.009 µM); selective for CYP1B1 over CYP1… |
5 mg |
37301-5 |
More Info
|
DMU2139 |
A CYP1B1 inhibitor (IC50 = 0.009 µM); selective for CYP1B1 over CYP1… |
50 mg |
37301-50 |
More Info
|
DMXAA |
A tumor vascular disrupting agent, inducing apoptosis in tumor vascular en… |
1 mg |
14617-1 |
More Info
|
DMXAA |
A tumor vascular disrupting agent, inducing apoptosis in tumor vascular en… |
10 mg |
14617-10 |
More Info
|
DMXAA |
A tumor vascular disrupting agent, inducing apoptosis in tumor vascular en… |
25 mg |
14617-25 |
More Info
|
DMXAA |
A tumor vascular disrupting agent, inducing apoptosis in tumor vascular en… |
5 mg |
14617-5 |
More Info
|
D-myo-Inositol-1,2-diphosphate (sodium salt) |
A member of the InsP family of small, soluble second messengers |
1 mg |
10008439-1 |
More Info
|
D-myo-Inositol-1,2-diphosphate (sodium salt) |
A member of the InsP family of small, soluble second messengers |
100 µg |
10008439-100 |
More Info
|
D-myo-Inositol-1,2-diphosphate (sodium salt) |
A member of the InsP family of small, soluble second messengers |
500 µg |
10008439-500 |
More Info
|
D-myo-Inositol-1,3-diphosphate (sodium salt) |
Ins(1,3)P2 can be dephosphorylated to Ins(1)P by inositol polyphosphate 3-… |
1 mg |
10008443-1 |
More Info
|
D-myo-Inositol-1,3-diphosphate (sodium salt) |
Ins(1,3)P2 can be dephosphorylated to Ins(1)P by inositol polyphosphate 3-… |
100 µg |
10008443-100 |
More Info
|
D-myo-Inositol-1,3-diphosphate (sodium salt) |
Ins(1,3)P2 can be dephosphorylated to Ins(1)P by inositol polyphosphate 3-… |
500 µg |
10008443-500 |
More Info
|
D-myo-Inositol-1,4-diphosphate (sodium salt) |
Ins(1,4)P2 can be dephosphorylated to Ins(4)P by inositol polyphosphate 1-… |
1 mg |
10008438-1 |
More Info
|
D-myo-Inositol-1,4-diphosphate (sodium salt) |
Ins(1,4)P2 can be dephosphorylated to Ins(4)P by inositol polyphosphate 1-… |
100 µg |
10008438-100 |
More Info
|
D-myo-Inositol-1,4-diphosphate (sodium salt) |
Ins(1,4)P2 can be dephosphorylated to Ins(4)P by inositol polyphosphate 1-… |
500 µg |
10008438-500 |
More Info
|
D-myo-Inositol-1,5-diphosphate (sodium salt) |
Ins(1,5)P2 is a member of the inositol phosphate (InsP) molecular family t… |
1 mg |
10008441-1 |
More Info
|
D-myo-Inositol-1,5-diphosphate (sodium salt) |
Ins(1,5)P2 is a member of the inositol phosphate (InsP) molecular family t… |
100 µg |
10008441-100 |
More Info
|
D-myo-Inositol-1,5-diphosphate (sodium salt) |
Ins(1,5)P2 is a member of the inositol phosphate (InsP) molecular family t… |
500 µg |
10008441-500 |
More Info
|
D-myo-Inositol-2,4-diphosphate (sodium salt) |
An intermediate compound produced by the dephosphorylation of either Ins-2… |
1 mg |
10008419-1 |
More Info
|
D-myo-Inositol-2,4-diphosphate (sodium salt) |
An intermediate compound produced by the dephosphorylation of either Ins-2… |
100 µg |
10008419-100 |
More Info
|
D-myo-Inositol-2,4-diphosphate (sodium salt) |
An intermediate compound produced by the dephosphorylation of either Ins-2… |
500 µg |
10008419-500 |
More Info
|
D-myo-Inositol-4,5-diphosphate (sodium salt) |
Ins(4,5)P2 is a metabolite of Ins(1,4,5)P3 that lacks a phosphate at the 1… |
1 mg |
10008418-1 |
More Info
|
D-myo-Inositol-4,5-diphosphate (sodium salt) |
Ins(4,5)P2 is a metabolite of Ins(1,4,5)P3 that lacks a phosphate at the 1… |
100 µg |
10008418-100 |
More Info
|
D-myo-Inositol-4,5-diphosphate (sodium salt) |
Ins(4,5)P2 is a metabolite of Ins(1,4,5)P3 that lacks a phosphate at the 1… |
500 µg |
10008418-500 |
More Info
|
D-myo-Inositol-1,2,3,4,5,6-hexaphosphate (sodium salt) |
An inositol phosphate with antioxidant and anticancer activities; chelates… |
1 mg |
10008415-1 |
More Info
|
D-myo-Inositol-1,2,3,4,5,6-hexaphosphate (sodium salt) |
An inositol phosphate with antioxidant and anticancer activities; chelates… |
10 mg |
10008415-10 |
More Info
|
D-myo-Inositol-1,2,3,4,5,6-hexaphosphate (sodium salt) |
An inositol phosphate with antioxidant and anticancer activities; chelates… |
5 mg |
10008415-5 |
More Info
|
D-myo-Inositol-1,2,3,4,5,6-hexaphosphate (sodium salt) |
An inositol phosphate with antioxidant and anticancer activities; chelates… |
500 µg |
10008415-500 |
More Info
|
D-myo-Inositol-1,3,4,5,6-pentaphosphate (ammonium salt) |
A member of the inositol phosphate (InsP) family of small, soluble second… |
1 mg |
10009851-1 |
More Info
|
D-myo-Inositol-1,3,4,5,6-pentaphosphate (ammonium salt) |
A member of the inositol phosphate (InsP) family of small, soluble second… |
100 µg |
10009851-100 |
More Info
|